Analyst	Recommendation	Action	Price target	Projected	Date
Tate Sullivan Maxim Group	Buy	Maintained	$3.00	+336%	10/20/2026
Dmitriy Pozdnyakov Freedom Capital Markets	Hold	Downgraded	$1.50	+118%	08/25/2026
Craig Irwin Roth MKM	Buy	Reiterated	$3.00	+336%	04/10/2026
Chris Pierce Needham	Hold	Reiterated	-	-	11/17/2025

All values in USD	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	5.79M	9.05M	3.13M	8.56M
Cost of goods sold	5.82M	7.44M	3.54M	7.04M
Cost of revenue	5.82M	7.44M	3.54M	7.04M
Research and development expenses	-	600.00K	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	4.64M	4.12M	6.10M	4.32M
Operating expense	4.84M	4.32M	6.30M	4.52M
Total operating expenses	10.66M	11.76M	9.84M	11.56M
Operating income	-4.87M	-2.71M	-6.71M	-3.00M
Other non operating income	-5.00K	-88.00K	-145.00K	-82.00K
EBT including unusual items	-4.87M	-2.74M	-6.86M	-3.08M
EBT excluding unusual items	-4.87M	-2.80M	-6.86M	-3.08M
Income tax expense	-	-406.00K	-	-
Effective tax rate	-	14.83%	-	-
Other operating expenses	-	-	-	-
Net income	-4.87M	-2.33M	-6.86M	-3.08M
Net profit margin	-84.14%	-25.77%	-219.15%	-35.97%
Earnings per share	-	-	-	-
Interest and investment income	14.00K	5.00K	5.00K	1.00K
Interest expense	-7.00K	-6.00K	-4.00K	-3.00K
Net interest expenses	7.00K	-1.00K	1.00K	-2.00K
Depreciation and amortization charges	100.00K	-400.00K	100.00K	100.00K
EBITDA	-3.97M	-1.85M	-5.83M	-2.21M
Gain or loss from assets sale	-	-	-	-

Ask anything